KISS1 and prostate carcinoma: In the functional analysis of the kisspeptin system across different types of cancer, we can first observe that in prostate cancer, according to the study by Kim et al. [14], the activation of EIF2AK2 by kisspeptin suppresses tumor growth and metastasis.